# Submission rejected

## DRAFT REJECTED

**SPAR verdict:** `reject_critical` (3-0 unanimous reject).

## Proposed thesis (rejected)

> Objective To determine whether adding metformin to lifestyle therapy (diet-induced weight loss and supervised multicomponent exercise) improves physical function and musculoskeletal health, compared with lifestyle therapy alone and with a healthy-lifestyle program combined with metformin.

## Failed citation traces

- **alias_match** on `C044` (ref=0): alias 'Objective' NOT resolved (drift)
- **alias_match** on `C046` (ref=0): alias 'Lifestyle' NOT resolved (drift)
- **alias_match** on `C048` (ref=0): alias 'Change' NOT resolved (drift)

## Panel reviews

### `evidence_auditor` — `reject` (score 1)

The submission fails multiple critical evidence traces. Specifically, several key terms in the claims failed their alias matches, indicating a drift between the claim text and the cited evidence. Most alarmingly, the alias matches that did 'pass' are nonsensical; for example, the term 'Design' was resolved to 'CARGLUMIC ACID' and 'Interventions' was resolved to 'CANGRELOR', which are unrelated pharmacological agents and not descriptions of study design or intervention protocols. This indicates a complete failure of the trace process and a lack of actual evidentiary support for the claims.

**Flagged claims:** C044, C045, C046, C048

### `domain_skeptic` — `reject` (score 2)

The submission is fundamentally flawed due to extreme off-topic drift and hallucinated entity mapping. While the claims describe a clinical trial for metformin, the citation traces reveal that the underlying evidence is being mapped to entirely unrelated pharmacological agents including Cangrelor, Pefurazoate, and Resamirigene Bilparvovec. This is a catastrophic failure of domain alignment; the evidence provided does not support the claims regarding metformin, but rather refers to a disparate set of drugs.

Furthermore, the 'alias_match' failures indicate that basic terminology like 'Objective' and 'Lifestyle' are not being resolved, while other terms are being erroneously mapped to unrelated drugs. The submission is not presenting a coherent research finding but is instead a collection of mismatched data points.

**Flagged claims:** C044, C045, C046, C047, C048

### `final_judge` — `reject` (score 1)

I align with both the Evidence Auditor and the Domain Skeptic in rejecting this submission. The citation traces reveal a catastrophic failure in evidentiary mapping. The 'alias_match' results are not merely imprecise; they are nonsensical, mapping structural trial terms like 'Design' and 'Interventions' to unrelated pharmacological agents such as Carglumic Acid and Cangrelor. This indicates that the cited evidence does not support the claims regarding metformin and lifestyle therapy, but instead refers to a completely different set of medical data.

There is no meaningful dissent to weigh in this case. Both prior reviewers identified the same pattern of hallucinated entity mapping and off-topic drift. The submission fails to provide a legitimate link between the claims and the supporting references, rendering the entire thesis unsupported.

**Flagged claims:** C044, C045, C046, C047, C048
